Bank of America
CRVO icon

Bank of America’s CervoMed CRVO Stock Holding History

Bank of America’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$95 – 5981
2025
Q4 		$95 Hold
12
– – ﹤0.01% 6829
2025
Q3 		$97 Sell
12
-868
-99% -$7.45K ﹤0.01% 7864
2025
Q2 		$5.53K Sell
880
-2,785
-76% -$23.7K ﹤0.01% 7285
2025
Q1 		$33.5K Sell
3,665
-1,595
-30% -$6.07K ﹤0.01% 6843
2024
Q4 		$12.3K Buy
5,260
+1,374
+35% +$13.4K ﹤0.01% 6933
2024
Q3 		$56.7K Sell
3,886
-2,483
-39% -$38.5K ﹤0.01% 6509
2024
Q2 		$109K Buy
+6,369
New +$139K ﹤0.01% 6219
2023
Q1 		– Sell
-3
Closed -$20 – 7874
2022
Q4 		$20 Buy
+3
New +$25 ﹤0.01% 7985
2022
Q1 		– Sell
-3
Closed – – 8330
2021
Q4 		$0 Sell
3
-4
-57% -$125 ﹤0.01% 8271
2021
Q3 		$0 Buy
7
+6
+600% +$250 ﹤0.01% 8138
2021
Q2 		$0 Buy
+1
New +$55 ﹤0.01% 7794
2020
Q2 		– Sell
-367
Closed -$9K – 6864
2020
Q1 		$9K Buy
367
+295
+410% +$8.95K ﹤0.01% 6384
2019
Q4 		$2K Buy
72
+71
+7,100% +$4.34K ﹤0.01% 6876
2019
Q3 		$0 Buy
+1
New +$161 ﹤0.01% 7280

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America's CRVO Position: Q1 2026 in Review

Bank of America sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 12 shares — an estimated $95 sold.

Bank of America first reported a position in CRVO in Q3 2019 and held it in 14 quarters. The position peaked at $109K in Q2 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Bank of America reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 12 CervoMed shares in Q1 2026, an estimated $95.
  • Bank of America first reported a position in CervoMed in Q3 2019 and held it in 14 quarters.
  • Bank of America's CervoMed position peaked at $109K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.